Daily non-political popular news in brief.
Walking prevents bone loss caused from prostate cancer treatment
10-28-2007 · EurekAlert!Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men, according to a study presented on Oct. 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Read more »
Keywords: walking, prevents, bone, loss, caused, prostate, cancer, treatment, prevent
« Previous | Next »
Similar news on "Walking prevents bone loss caused from prostate cancer treatment":
- Commonly Used Antidepressants May Prevent Bone Loss
10-13-2006 · ScienceDaily
Scientists at the Forsyth Institute have found that fluoxetine, a drug used in the treatment of depression and obsessive-compulsive disorders, increases bone mass. The team of researchers analyzed the ability of fluoxetine to stimulate new bone formation under normal conditions and to block bone loss caused by inflammation or estrogen loss due to ovariectomy. They found that the antidepressant induced the formation of new bone under normal conditions and reversed total bone loss triggered by inflammation.
Similar news · Read more »
- Nonhormonal drug reduces hot flashes in men treated for prostate cancer
06-03-2007 · EurekAlert!
North Central Cancer Treatment Group researchers based at Mayo Clinic in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.
Similar news · Read more »
- Weekly dose of osteoporosis drug prevents bone loss after breast cancer treatment
09-18-2007 · EurekAlert!
Breast cancer survivors who took a weekly dose of risedronate, sold as Actonel, lost significantly less bone than those who did not take the drug, according to a two-year study from the University of Pittsburgh School of Medicine presented this week at the 29th annual meeting of the American Society for Bone and Mineral Research.Researchers evaluated 87 women enrolled in the Prevention of Osteoporosis in Postmenopausal Women with Breast Cancer Following Chemotherapy study.
Similar news · Read more »
- Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054
09-25-2007 · EurekAlert!
New Phase II data presented today suggest that ZD4054, a novel compound in development for the treatment of men with hormone-resistant prostate cancer, could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.1 Patients who received ZD4054 10mg once-daily experienced a 45 percent reduction in the risk of death compared to placebo.
Similar news · Read more »
- Forsyth scientists find linkages between serotonin reuptake inhibitors and bone mass
10-13-2006 · EurekAlert!
Scientists at the Forsyth Institute have found that fluoxetine, a drug used in the treatment of depression and obsessive-compulsive disorders, increases bone mass. The team of researchers analyzed the ability of fluoxetine to stimulate new bone formation under normal conditions and to block bone loss caused by inflammation or estrogen loss due to ovariectomy. They found that the antidepressant induced the formation of new bone under normal conditions and reversed total bone loss triggered by inflammation.
Similar news · Read more »
- Children with cancer risk fragile bones
02-26-2007 · EurekAlert!
Physicians caring for children with cancer should be on the lookout for signs of bone fragility caused by disease and treatment, according to a new report.
Similar news · Read more »
- Australian researchers develop treatment to treat obesity
11-06-2007 · EurekAlert!
A team of Australian researchers have developed a novel way to control the extreme weight loss, common in late-stage cancer, which often speeds death. The findings published today in Nature Medicine suggest it may soon be possible to prevent this condition, giving people the strength to survive treatment and improve their chances of recovery.
Similar news · Read more »
- Other highlights in the March 7 JNCI
03-06-2007 · EurekAlert!
Other highlights in the March 7 JNCI include a study showing how changes in breast density affect breast cancer risk, a new potential treatment for prostate cancer, a gene that influences the formation of benign bone tumors, and an essay on the additional health benefits of breast cancer prevention drugs.
Similar news · Read more »
- Jefferson scientists find aging gene also protects against prostate cancer development
11-27-2006 · EurekAlert!
Cancer researchers have found that a gene that is involved in regulating aging also blocks prostate cancer cell growth. They have shown that the enzyme SIRT1 can block the growth of treatment-resistant prostate cancer cells that overexpress a mutation for the androgen receptor. The scientists hope the newly found connection will aid in better understanding the development of prostate cancer and lead to new drugs against the disease.
Similar news · Read more »
- Radiation therapy combo cures prostate cancer long-term
01-04-2007 · EurekAlert!
Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.
Similar news · Read more »
